After her consultation the prescription was sent to the pharmacy and she got her medication a few days later
SURMOUNT-5 was a 72-week, open-label, Phase 3b randomised trial of 751 adults with obesity but without diabetes, comparing maximum-tolerated tirzepatide (10 or 15 mg) against maximum-tolerated semaglutide (1.7 or 2.4 mg)
Decreasing gluconeogenesis
Get started today and unlock the path to lasting results
IF you did not hold your medication and you have no GI symptoms, proceed with full stomach precautions. Consider ultrasound to see if stomach is full
(239) 323-9636 www.PhysiciansRehab.com 6150 Diamond Centre Court, Bldg.100, Fort Myers, FL 33912 3417 Tamiami Trail, Unit A, Port Charlotte, FL 33952 5668 Strand Court, Naples, FL 34110 The Villages 733 CR 466, Lady Lake , FL 32159 The Villages 4064 E SR 44, Suite A, Wildwood, FL 34785